{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:44:26Z","timestamp":1793684666059,"version":"4.5.1"},"reference-count":39,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"Italian Ministry of Health\u2013Ricerca Corrente","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Med Oncol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Despite the availability of several first-line (1L) systemic therapies for metastatic renal cell carcinoma (mRCC), no validated biomarkers currently guide the selection of 1L systemic treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To identify baseline clinical features associated with 1L treatment selection in a large real-world mRCC population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Meet-URO 33\u2013REGAL is a multicenter study with prospective and retrospective components, enrolling patients with mRCC receiving 1L systemic therapy since January 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Baseline patient and disease characteristics were analyzed to compare treatment selection among dual immune checkpoint inhibitor therapy (ICI\u2013ICI), ICI plus tyrosine kinase inhibitor combinations (ICI\u2013TKI), and TKI monotherapy. Multivariable logistic regression models were used to evaluate clinical features associated with pairwise treatment selection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 1695 patients from 58 centers were included: 248 (14.6%) received TKI monotherapy, 338 (20.0%) ICI\u2013ICI, and 1109 (65.4%) ICI\u2013TKI. ICI\u2013ICI was more commonly selected in patients with sarcomatoid features (14.5% vs 7.4% for ICI\u2013TKI,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) intermediate\/poor-risk disease (92.0% vs 80.1%,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.001). In multivariable analysis, compared with TKI monotherapy, ICI\u2013TKI selection was associated with IMDC intermediate-risk disease (odds ratio (OR) 2.16, 95% confidence interval (CI) 1.25\u20133.74,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.006), poor-risk disease (OR 2.89, 95% CI 1.38\u20136.06,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.005), and bone metastases (OR 1.79, 95% CI 1.29\u20132.49,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.001). In regimen-specific comparisons, nivolumab plus cabozantinib was associated with bone metastases and non-clear cell histology; pembrolizumab plus lenvatinib with eastern cooperative oncology group (ECOG) performance status 0 and pancreatic involvement; and nivolumab plus ipilimumab with cardiovascular and metabolic comorbidities and lymph node metastases. TKI monotherapy was more commonly selected in older patients and those with comorbidities, consistent with a more selected clinical phenotype in routine clinical practice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Meet-URO 33 provides a real-world snapshot of 1L decision-making in mRCC. Distinct clinical patterns, including histology, metastatic sites, performance status, comorbidities, and prognostic risk, were associated with treatment selection. These findings characterize clinical phenotypes in routine practice and provide context for future effectiveness, safety, and treatment-sequencing analyses of 1L therapeutic strategies within the Meet-URO 33 cohort over time.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17588359261470598","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:12:30Z","timestamp":1787267550000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33\u2014REGAL study"],"prefix":"10.1177","volume":"18","author":[{"given":"Davide","family":"Bimbatti","sequence":"first","affiliation":[{"name":"Oncology 1 Unit, Istituto Oncologico Veneto IOV\u2013IRCCS, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Nasso","sequence":"additional","affiliation":[{"name":"Medical Oncology, Ospedale Santa Corona, Pietra Ligure, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domiziana","family":"Aspden","sequence":"additional","affiliation":[{"name":"University of Turin, A.O.U. Citt\u00e0 della Salute e della Scienza di Torino, Ospedale Molinette, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Buti","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, University Hospital of Parma, Parma, Italy"},{"name":"Medicine and Surgery Department, University of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Antonj","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Signori","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Section of Biostatistics, University of Genova, Via Pastore 1, Genoa 16132, Italy"},{"name":"IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, Genoa 16132, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Verzoni","sequence":"additional","affiliation":[{"name":"Oncologia Medica Genitourinaria, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Lolli","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori,\u201d Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena","family":"Di Napoli","sequence":"additional","affiliation":[{"name":"Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Fanelli","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Department of Medicine (DAME), University of Udine, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"De Lucia","sequence":"additional","affiliation":[{"name":"Unit of Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Masini","sequence":"additional","affiliation":[{"name":"Medical Oncology. Comprehensive Cancer Centre, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giandomenico","family":"Roviello","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Firenze, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Arduini","sequence":"additional","affiliation":[{"name":"Universit\u00e0 Cattolica del Sacro Cuore, Facolt\u00e0 di Medicina e Chirurgia, Rome, Italy"},{"name":"Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Filippi","sequence":"additional","affiliation":[{"name":"Medical Oncology 1U, Azienda Ospedaliero-Universitaria Citt\u00e0 della Salute e della Scienza di Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Mennitto","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Azienda Ospedaliera Universitaria \u201cMaggiore Della Carit\u00e0,\u201d Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella","family":"Sorar\u00f9","sequence":"additional","affiliation":[{"name":"U.O. Oncologia, Ospedale di Camposampiero, Camposampiero, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Bozza","sequence":"additional","affiliation":[{"name":"Medical Oncology IRCSS CROB, Rionero in Vulture, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Formisano","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery at University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Messina","sequence":"additional","affiliation":[{"name":"Oncology Unit, A.R.N.A.S. Civico, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Bonomi","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Guida","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, Santa Maria Hospital, Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Fantinel","sequence":"additional","affiliation":[{"name":"Department of Oncology, Azienda Ospedaliera Universitaria Integrata di Verona, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Scagliarini","sequence":"additional","affiliation":[{"name":"Deparment of Medical Oncology, AORN \u201cA. Cardarelli,\u201d Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giuseppa","family":"Vitale","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Chiellino","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5423-3158","authenticated-orcid":false,"given":"Brigida Anna","family":"Maiorano","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IRRCS San Raffaele Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Maria","family":"Deppieri","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, AULSS 3 Serenissima, Mestre-Venice, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Andrea","family":"Zucali","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy"},{"name":"Department of Oncology, IRCCS, Humanitas Clinical and Research Center, Rozzano, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2157-3740","authenticated-orcid":false,"given":"Alessia","family":"Cavo","sequence":"additional","affiliation":[{"name":"Oncology Unit, ASL3-Villa Scassi Hospital, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Caserta","sequence":"additional","affiliation":[{"name":"Oncology Unit, Santa Maria della Misericordia Hospital Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"La Russa","sequence":"additional","affiliation":[{"name":"Department of Oncology, Ospedale San Bortolo, Vicenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6921-714X","authenticated-orcid":false,"given":"Vincenza","family":"Conteduca","sequence":"additional","affiliation":[{"name":"Unit of Medical Oncology and Biomolecular Therapy and CREATE Center for Research and Innovation in Medicine, Department of Medical and Surgical Sciences, University of Foggia, Policlinico Riuniti, Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Maines","sequence":"additional","affiliation":[{"name":"Medical Oncology, Santa Chiara Hospital, Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Zai","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pierantoni","sequence":"additional","affiliation":[{"name":"Oncology 3 Unit, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Icardi","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit 2, Ospedale Molinette, Azienda Ospedaliero-Universitaria Citt\u00e0 della Salute e della Scienza di Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Rescigno","sequence":"additional","affiliation":[{"name":"Department of Oncology, Candiolo Cancer Institute FPO-IRCCS, Turin, Italy"},{"name":"Translational and Clinical Research Institute, Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2173-8245","authenticated-orcid":false,"given":"Fabrizio","family":"Di Costanzo","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery at University of Naples Federico II, Naples, Italy"},{"name":"Translational and Clinical Research Institute, Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Luigi","family":"Banna","sequence":"additional","affiliation":[{"name":"Department of Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth, UK"},{"name":"Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0546-6304","authenticated-orcid":false,"given":"Sara Elena","family":"Rebuzzi","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit 2, Ospedale Molinette, Azienda Ospedaliero-Universitaria Citt\u00e0 della Salute e della Scienza di Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.10.019"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2021.03.001"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-023-00978-2"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2351669"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102377"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2025.2457373"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.05.537"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/17588359211019642"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12319-1"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyag203"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-8-200710160-00010"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2019.05.009"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.10.011"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005249"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100634"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05014-z"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.15586\/jkcvhl.v12i4.403"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2025.102336"},{"key":"e_1_3_4_20_2","article-title":"Prognostic validation of the Meet-URO score compared with the IMDC score in metastatic renal cell carcinoma patients receiving first-line systemic treatment (Meet-URO 33 study)","volume":"36","author":"Rebuzzi SE","year":"2025","unstructured":"Rebuzzi SE, Buti S, Verzoni E, et al. Prognostic validation of the Meet-URO score compared with the IMDC score in metastatic renal cell carcinoma patients receiving first-line systemic treatment (Meet-URO 33 study). Ann Oncol 2025; 36(Suppl.): S1422\u2013S1423.","journal-title":"Ann Oncol"},{"key":"e_1_3_4_21_2","article-title":"Prognostic performance of the Meet-URO score in an international real-world cohort of metastatic renal cell carcinoma patients receiving first-line immune-combinations","volume":"36","author":"Rebuzzi SE","year":"2025","unstructured":"Rebuzzi SE, Ghose A, Brown NS, et al. Prognostic performance of the Meet-URO score in an international real-world cohort of metastatic renal cell carcinoma patients receiving first-line immune-combinations. Ann Oncol. 2025; 36(Suppl.): S1418.","journal-title":"Ann Oncol"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2020.100030"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294039"},{"issue":"3","key":"e_1_3_4_24_2","first-page":"219","article-title":"Safety and adverse event management of VEGFR-TKIs in patients with metastatic renal cell carcinoma","volume":"29","author":"Wood LS","year":"2025","unstructured":"Wood LS, Lim ZD. Safety and adverse event management of VEGFR-TKIs in patients with metastatic renal cell carcinoma. Clin J Oncol Nurs 2025; 29(3): 219\u2013229.","journal-title":"Clin J Oncol Nurs"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-023-01845-2"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2024.01.010"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2458948"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01944"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00276-0"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.03.016"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2021-0157"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102374"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.21869"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.07.727"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102792"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2024.102078"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.762540"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59010150"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.134564"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108499"}],"container-title":["Therapeutic Advances in Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17588359261470598","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17588359261470598","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17588359261470598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T10:49:05Z","timestamp":1787482145000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17588359261470598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":39,"alternative-id":["10.1177\/17588359261470598"],"URL":"https:\/\/doi.org\/10.1177\/17588359261470598","relation":{},"ISSN":["1758-8359","1758-8359"],"issn-type":[{"value":"1758-8359","type":"print"},{"value":"1758-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"article-number":"17588359261470598"}}